Smoking Cessation and Nicotine De-Addiction Market – Industry Analysis and Forecast (2022-2029)


Smoking Cessation and Nicotine De-Addiction Market is expected to grow at a CAGR of 18.90% during the forecast period. Global Smoking Cessation and Nicotine DeAddiction Market is expected to reach USD 51.80 Bn by 2029.

Smoking Cessation and Nicotine De-Addiction Market Dynamics:

Growing awareness among cigarette smokers about the health disadvantages of smoking such as lung cancer, cardiac diseases, and other respiratory problems, has forced the global  market. Initiatives assisted by governments to make awareness concerning the harmful effects of smoking with the help of information brochures, warning labels, discouraging imagery on cigarette packages, television ads, and newspapers are also driving the growth of the global smoking cessation and nicotine de-addiction market.

There are also some non-government organizations functioning to help and educate people to stop smoking and are frequently involved in reducing the number of customers. This will allow the smoking cessation and nicotine de-addiction market to increase in the future. Moreover, the availability of a large range of nicotine replacement therapy (NRT) products through retail & online selling platforms is also fueling the growth . Nevertheless, less consciousness about smoking cessation products in emerging economies is hindering the growth of the global smoking cessation and nicotine de-addiction market.Smoking Cessation and Nicotine De-Addiction MarketTo know about the Research Methodology :- Request Free Sample Report

Smoking Cessation and Nicotine De-Addiction Market Regional Insights:

According to the product type, the e-cigarettes segment is expected to grow at the highest CAGR of XX% throughout the forecasted period and this is due to e-cigarettes' capacity to replicate the same sensation as smoking a conventional cigarette while reducing the health risks related with the latter. The increasing acceptance of e-cigarettes is on account of the obtainability of a variation of flavors and nicotine concentrations.Smoking Cessation and Nicotine De-Addiction MarketRegion-wise, the North Americas is leading the smoking cessation and nicotine de-addiction market with its innovations in smoking cessation products, and account for about 45% of the global smoking cessation and nicotine de-addiction market. Asia-Pacific is expected to have the largest growth rate throughout the forecast period thanks to high tobacco consumption in this region, in addition to rising disposable income.

The objective of the report is to present comprehensive analysis of Global Smoking Cessation and Nicotine De-Addiction Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Smoking Cessation and Nicotine De-Addiction Market dynamics, structure by analyzing the market segments, and project the Global Smoking Cessation and Nicotine De-Addiction Market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Global  Market make the report investor’s guide.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Smoking Cessation and Nicotine De-Addiction Market Scope: Inquire before buying






Smoking Cessation and Nicotine De-Addiction Market




Report Coverage
Details




Base Year:
2021
Forecast Period:
2022-2029




Historical Data:
2017 to 2021
Market Size in 2021:
US $ 12.97 Bn.




Forecast Period 2022 to 2029 CAGR:
18.9%
Market Size in 2029:
US $ 51.80 Bn.




 Segments Covered:
by Product Type
•Products (with Nicotine)

o OTC Products
o E-cigarettes
o Nicotine Gums (NRT)
o Nicotine Patches (NRT)
o Nicotine Lozenges (NRT)
o Nicotine Tablets (NRT)
o Prescription Products
o Nicotine Sprays (NRT)
o Nicotine Inhalers (NRT)

• Products (without Nicotine)

o Prescription Products
o Zyban
o Chantix






by Distribution Channel
• Online
• Offline






Smoking Cessation and Nicotine De-Addiction Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Smoking Cessation and Nicotine De-Addiction Market Key Players:

• Pfizer Inc.
• GlaxoSmithKline plc (GSK)
• Cipla Ltd.
• Johnson & Johnson (J&J)
• ITC Ltd.
• Takeda Pharmaceutical Company Ltd.
• Alkalon A/S
• 22nd Century Group, Inc.
• Strides Pharma Science Ltd.
• JUUL Labs, Inc.
• Imperial Brands
• Japan Tobacco Inc.
• British American Tobacco
• Perrigo Company plc
• Fertin Pharma

Frequently Asked Questions:

1. Which region has the largest share in Global Smoking Cessation and Nicotine De-Addiction Market?
Ans: North America region held the highest share in 2021.

2. What is the growth rate of Global Smoking Cessation and Nicotine De-Addiction Market?
Ans: The Global Smoking Cessation and Nicotine De-Addiction Market is growing at a CAGR of 18.90% during forecasting period 2022-2029.

3. What is scope of the Global Smoking Cessation and Nicotine De-Addiction market report?
Ans: Global Smoking Cessation and Nicotine De-Addiction Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Smoking Cessation and Nicotine De-Addiction market?
Ans: The important key players in the Global Smoking Cessation and Nicotine De-Addiction Market are – Pfizer Inc., GlaxoSmithKline plc (GSK), Cipla Ltd., Johnson & Johnson (J&J), ITC Ltd., Takeda Pharmaceutical Company Ltd., Alkalon A/S, 22nd Century Group, Inc., Strides Pharma Science Ltd., JUUL Labs, Inc., Imperial Brands, Japan Tobacco Inc., British American Tobacco, Perrigo Company plc, and Fertin Pharma.

5. What is the study period of this market?
Ans: The Global Smoking Cessation and Nicotine De-Addiction Market is studied from 2021 to 2029. 




Global Smoking Cessation and Nicotine De-Addiction Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Smoking Cessation and Nicotine De-Addiction Market, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
7.4. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Bn) Forecast, by Product Type
7.5. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, by Product Type
7.6. Global Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis, by Product Type

8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
8.4. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Bn) Forecast, by Distribution Channel
8.5. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, by Distribution Channel
8.6. Global Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis, by Distribution Channel

9. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, by Region
9.1. Global Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Region
9.2. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Bn) Forecast, by Region
9.3. Global Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis, by Region

10. North America Smoking Cessation and Nicotine De-Addiction Market Analysis
10.1. Key Findings
10.2. North America Smoking Cessation and Nicotine De-Addiction Market Overview
10.3. North America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
10.4. North America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
10.4.1. Products (with Nicotine)
10.4.1.1. OTC Products
10.4.1.1.1. E-cigarettes
10.4.1.1.2. Nicotine Gums (NRT)
10.4.1.1.3. Nicotine Patches (NRT)
10.4.1.1.4. Nicotine Lozenges (NRT)
10.4.1.1.5. Nicotine Tablets (NRT)
10.4.1.2. Prescription Products
10.4.1.2.1. Nicotine Sprays (NRT)
10.4.1.2.2. Nicotine Inhalers (NRT)
10.4.2. Products (without Nicotine)
10.4.2.1. Prescription Products
10.4.2.1.1. Zyban
10.4.2.1.2. Chantix
10.5. North America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
10.6. North America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
10.6.1. Online
10.6.2. Offline
10.7. North America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
10.8. North America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
10.10. U.S. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
10.10.1. Products (with Nicotine)
10.10.1.1. OTC Products
10.10.1.1.1. E-cigarettes
10.10.1.1.2. Nicotine Gums (NRT)
10.10.1.1.3. Nicotine Patches (NRT)
10.10.1.1.4. Nicotine Lozenges (NRT)
10.10.1.1.5. Nicotine Tablets (NRT)
10.10.1.2. Prescription Products
10.10.1.2.1. Nicotine Sprays (NRT)
10.10.1.2.2. Nicotine Inhalers (NRT)
10.10.2. Products (without Nicotine)
10.10.2.1. Prescription Products
10.10.2.1.1. Zyban
10.10.2.1.2. Chantix
10.11. U.S. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
10.11.1. Online
10.11.2. Offline
10.12. Canada Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
10.12.1. Products (with Nicotine)
10.12.1.1. OTC Products
10.12.1.1.1. E-cigarettes
10.12.1.1.2. Nicotine Gums (NRT)
10.12.1.1.3. Nicotine Patches (NRT)
10.12.1.1.4. Nicotine Lozenges (NRT)
10.12.1.1.5. Nicotine Tablets (NRT)
10.12.1.2. Prescription Products
10.12.1.2.1. Nicotine Sprays (NRT)
10.12.1.2.2. Nicotine Inhalers (NRT)
10.12.2. Products (without Nicotine)
10.12.2.1. Prescription Products
10.12.2.1.1. Zyban
10.12.2.1.2. Chantix
10.13. Canada Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
10.13.1. Online
10.13.2. Offline
10.14. North America Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
10.14.1. By Product Type
10.14.2. By Distribution Channel
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Development

11. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis
11.1. Key Findings
11.2. Europe Smoking Cessation and Nicotine De-Addiction Market Overview
11.3. Europe Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
11.4. Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.4.1. Products (with Nicotine)
11.4.1.1. OTC Products
11.4.1.1.1. E-cigarettes
11.4.1.1.2. Nicotine Gums (NRT)
11.4.1.1.3. Nicotine Patches (NRT)
11.4.1.1.4. Nicotine Lozenges (NRT)
11.4.1.1.5. Nicotine Tablets (NRT)
11.4.1.2. Prescription Products
11.4.1.2.1. Nicotine Sprays (NRT)
11.4.1.2.2. Nicotine Inhalers (NRT)
11.4.2. Products (without Nicotine)
11.4.2.1. Prescription Products
11.4.2.1.1. Zyban
11.4.2.1.2. Chantix
11.5. Europe Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
11.6. Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.6.1. Online
11.6.2. Offline
11.7. Europe Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
11.8. Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
11.10. Germany Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.10.1. Products (with Nicotine)
11.10.1.1. OTC Products
11.10.1.1.1. E-cigarettes
11.10.1.1.2. Nicotine Gums (NRT)
11.10.1.1.3. Nicotine Patches (NRT)
11.10.1.1.4. Nicotine Lozenges (NRT)
11.10.1.1.5. Nicotine Tablets (NRT)
11.10.1.2. Prescription Products
11.10.1.2.1. Nicotine Sprays (NRT)
11.10.1.2.2. Nicotine Inhalers (NRT)
11.10.2. Products (without Nicotine)
11.10.2.1. Prescription Products
11.10.2.1.1. Zyban
11.10.2.1.2. Chantix
11.11. Germany Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.11.1. Online
11.11.2. Offline
11.12. U.K. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.12.1. Products (with Nicotine)
11.12.1.1. OTC Products
11.12.1.1.1. E-cigarettes
11.12.1.1.2. Nicotine Gums (NRT)
11.12.1.1.3. Nicotine Patches (NRT)
11.12.1.1.4. Nicotine Lozenges (NRT)
11.12.1.1.5. Nicotine Tablets (NRT)
11.12.1.2. Prescription Products
11.12.1.2.1. Nicotine Sprays (NRT)
11.12.1.2.2. Nicotine Inhalers (NRT)
11.12.2. Products (without Nicotine)
11.12.2.1. Prescription Products
11.12.2.1.1. Zyban
11.12.2.1.2. Chantix
11.13. U.K. Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.13.1. Online
11.13.2. Offline
11.14. France Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.14.1. Products (with Nicotine)
11.14.1.1. OTC Products
11.14.1.1.1. E-cigarettes
11.14.1.1.2. Nicotine Gums (NRT)
11.14.1.1.3. Nicotine Patches (NRT)
11.14.1.1.4. Nicotine Lozenges (NRT)
11.14.1.1.5. Nicotine Tablets (NRT)
11.14.1.2. Prescription Products
11.14.1.2.1. Nicotine Sprays (NRT)
11.14.1.2.2. Nicotine Inhalers (NRT)
11.14.2. Products (without Nicotine)
11.14.2.1. Prescription Products
11.14.2.1.1. Zyban
11.14.2.1.2. Chantix
11.15. France Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.15.1. Online
11.15.2. Offline
11.16. Italy Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.16.1. Products (with Nicotine)
11.16.1.1. OTC Products
11.16.1.1.1. E-cigarettes
11.16.1.1.2. Nicotine Gums (NRT)
11.16.1.1.3. Nicotine Patches (NRT)
11.16.1.1.4. Nicotine Lozenges (NRT)
11.16.1.1.5. Nicotine Tablets (NRT)
11.16.1.2. Prescription Products
11.16.1.2.1. Nicotine Sprays (NRT)
11.16.1.2.2. Nicotine Inhalers (NRT)
11.16.2. Products (without Nicotine)
11.16.2.1. Prescription Products
11.16.2.1.1. Zyban
11.16.2.1.2. Chantix
11.17. Italy Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.17.1. Online
11.17.2. Offline
11.18. Spain Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.18.1. Products (with Nicotine)
11.18.1.1. OTC Products
11.18.1.1.1. E-cigarettes
11.18.1.1.2. Nicotine Gums (NRT)
11.18.1.1.3. Nicotine Patches (NRT)
11.18.1.1.4. Nicotine Lozenges (NRT)
11.18.1.1.5. Nicotine Tablets (NRT)
11.18.1.2. Prescription Products
11.18.1.2.1. Nicotine Sprays (NRT)
11.18.1.2.2. Nicotine Inhalers (NRT)
11.18.2. Products (without Nicotine)
11.18.2.1. Prescription Products
11.18.2.1.1. Zyban
11.18.2.1.2. Chantix
11.19. Spain Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.19.1. Online
11.19.2. Offline
11.20. Rest of Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
11.20.1. Products (with Nicotine)
11.20.1.1. OTC Products
11.20.1.1.1. E-cigarettes
11.20.1.1.2. Nicotine Gums (NRT)
11.20.1.1.3. Nicotine Patches (NRT)
11.20.1.1.4. Nicotine Lozenges (NRT)
11.20.1.1.5. Nicotine Tablets (NRT)
11.20.1.2. Prescription Products
11.20.1.2.1. Nicotine Sprays (NRT)
11.20.1.2.2. Nicotine Inhalers (NRT)
11.20.2. Products (without Nicotine)
11.20.2.1. Prescription Products
11.20.2.1.1. Zyban
11.20.2.1.2. Chantix
11.21. Rest of Europe Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
11.21.1. Online
11.21.2. Offline
11.22. Europe Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
11.22.1. By Product Type
11.22.2. By Distribution Channel
11.23. PEST Analysis
11.24. Key Trends
11.25. Key Development

12. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis
12.1. Key Findings
12.2. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Overview
12.3. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
12.4. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.4.1. Products (with Nicotine)
12.4.1.1. OTC Products
12.4.1.1.1. E-cigarettes
12.4.1.1.2. Nicotine Gums (NRT)
12.4.1.1.3. Nicotine Patches (NRT)
12.4.1.1.4. Nicotine Lozenges (NRT)
12.4.1.1.5. Nicotine Tablets (NRT)
12.4.1.2. Prescription Products
12.4.1.2.1. Nicotine Sprays (NRT)
12.4.1.2.2. Nicotine Inhalers (NRT)
12.4.2. Products (without Nicotine)
12.4.2.1. Prescription Products
12.4.2.1.1. Zyban
12.4.2.1.2. Chantix
12.5. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
12.6. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.6.1. Online
12.6.2. Offline
12.7. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
12.8. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
12.10. China Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.10.1. Products (with Nicotine)
12.10.1.1. OTC Products
12.10.1.1.1. E-cigarettes
12.10.1.1.2. Nicotine Gums (NRT)
12.10.1.1.3. Nicotine Patches (NRT)
12.10.1.1.4. Nicotine Lozenges (NRT)
12.10.1.1.5. Nicotine Tablets (NRT)
12.10.1.2. Prescription Products
12.10.1.2.1. Nicotine Sprays (NRT)
12.10.1.2.2. Nicotine Inhalers (NRT)
12.10.2. Products (without Nicotine)
12.10.2.1. Prescription Products
12.10.2.1.1. Zyban
12.10.2.1.2. Chantix
12.11. China Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.11.1. Online
12.11.2. Offline
12.12. India Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.12.1. Products (with Nicotine)
12.12.1.1. OTC Products
12.12.1.1.1. E-cigarettes
12.12.1.1.2. Nicotine Gums (NRT)
12.12.1.1.3. Nicotine Patches (NRT)
12.12.1.1.4. Nicotine Lozenges (NRT)
12.12.1.1.5. Nicotine Tablets (NRT)
12.12.1.2. Prescription Products
12.12.1.2.1. Nicotine Sprays (NRT)
12.12.1.2.2. Nicotine Inhalers (NRT)
12.12.2. Products (without Nicotine)
12.12.2.1. Prescription Products
12.12.2.1.1. Zyban
12.12.2.1.2. Chantix
12.13. India Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.13.1. Online
12.13.2. Offline
12.14. Japan Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.14.1. Products (with Nicotine)
12.14.1.1. OTC Products
12.14.1.1.1. E-cigarettes
12.14.1.1.2. Nicotine Gums (NRT)
12.14.1.1.3. Nicotine Patches (NRT)
12.14.1.1.4. Nicotine Lozenges (NRT)
12.14.1.1.5. Nicotine Tablets (NRT)
12.14.1.2. Prescription Products
12.14.1.2.1. Nicotine Sprays (NRT)
12.14.1.2.2. Nicotine Inhalers (NRT)
12.14.2. Products (without Nicotine)
12.14.2.1. Prescription Products
12.14.2.1.1. Zyban
12.14.2.1.2. Chantix
12.15. Japan Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.15.1. Online
12.15.2. Offline
12.16. ASEAN Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.16.1. Products (with Nicotine)
12.16.1.1. OTC Products
12.16.1.1.1. E-cigarettes
12.16.1.1.2. Nicotine Gums (NRT)
12.16.1.1.3. Nicotine Patches (NRT)
12.16.1.1.4. Nicotine Lozenges (NRT)
12.16.1.1.5. Nicotine Tablets (NRT)
12.16.1.2. Prescription Products
12.16.1.2.1. Nicotine Sprays (NRT)
12.16.1.2.2. Nicotine Inhalers (NRT)
12.16.2. Products (without Nicotine)
12.16.2.1. Prescription Products
12.16.2.1.1. Zyban
12.16.2.1.2. Chantix
12.17. ASEAN Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.17.1. Online
12.17.2. Offline
12.18. Rest of Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
12.18.1. Products (with Nicotine)
12.18.1.1. OTC Products
12.18.1.1.1. E-cigarettes
12.18.1.1.2. Nicotine Gums (NRT)
12.18.1.1.3. Nicotine Patches (NRT)
12.18.1.1.4. Nicotine Lozenges (NRT)
12.18.1.1.5. Nicotine Tablets (NRT)
12.18.1.2. Prescription Products
12.18.1.2.1. Nicotine Sprays (NRT)
12.18.1.2.2. Nicotine Inhalers (NRT)
12.18.2. Products (without Nicotine)
12.18.2.1. Prescription Products
12.18.2.1.1. Zyban
12.18.2.1.2. Chantix
12.19. Rest of Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
12.19.1. Online
12.19.2. Offline
12.20. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
12.20.1. By Product Type
12.20.2. By Distribution Channel
12.21. PEST Analysis
12.22. Key Trends
12.23. Key Development

13. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Overview
13.3. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
13.4. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.4.1. Products (with Nicotine)
13.4.1.1. OTC Products
13.4.1.1.1. E-cigarettes
13.4.1.1.2. Nicotine Gums (NRT)
13.4.1.1.3. Nicotine Patches (NRT)
13.4.1.1.4. Nicotine Lozenges (NRT)
13.4.1.1.5. Nicotine Tablets (NRT)
13.4.1.2. Prescription Products
13.4.1.2.1. Nicotine Sprays (NRT)
13.4.1.2.2. Nicotine Inhalers (NRT)
13.4.2. Products (without Nicotine)
13.4.2.1. Prescription Products
13.4.2.1.1. Zyban
13.4.2.1.2. Chantix
13.5. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
13.6. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.6.1. Online
13.6.2. Offline
13.7. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
13.8. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
13.10. GCC Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.10.1. Products (with Nicotine)
13.10.1.1. OTC Products
13.10.1.1.1. E-cigarettes
13.10.1.1.2. Nicotine Gums (NRT)
13.10.1.1.3. Nicotine Patches (NRT)
13.10.1.1.4. Nicotine Lozenges (NRT)
13.10.1.1.5. Nicotine Tablets (NRT)
13.10.1.2. Prescription Products
13.10.1.2.1. Nicotine Sprays (NRT)
13.10.1.2.2. Nicotine Inhalers (NRT)
13.10.2. Products (without Nicotine)
13.10.2.1. Prescription Products
13.10.2.1.1. Zyban
13.10.2.1.2. Chantix
13.11. GCC Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.11.1. Online
13.11.2. Offline
13.12. South Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.12.1. Products (with Nicotine)
13.12.1.1. OTC Products
13.12.1.1.1. E-cigarettes
13.12.1.1.2. Nicotine Gums (NRT)
13.12.1.1.3. Nicotine Patches (NRT)
13.12.1.1.4. Nicotine Lozenges (NRT)
13.12.1.1.5. Nicotine Tablets (NRT)
13.12.1.2. Prescription Products
13.12.1.2.1. Nicotine Sprays (NRT)
13.12.1.2.2. Nicotine Inhalers (NRT)
13.12.2. Products (without Nicotine)
13.12.2.1. Prescription Products
13.12.2.1.1. Zyban
13.12.2.1.2. Chantix
13.13. South Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.13.1. Online
13.13.2. Offline
13.14. Rest of Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
13.14.1. Products (with Nicotine)
13.14.1.1. OTC Products
13.14.1.1.1. E-cigarettes
13.14.1.1.2. Nicotine Gums (NRT)
13.14.1.1.3. Nicotine Patches (NRT)
13.14.1.1.4. Nicotine Lozenges (NRT)
13.14.1.1.5. Nicotine Tablets (NRT)
13.14.1.2. Prescription Products
13.14.1.2.1. Nicotine Sprays (NRT)
13.14.1.2.2. Nicotine Inhalers (NRT)
13.14.2. Products (without Nicotine)
13.14.2.1. Prescription Products
13.14.2.1.1. Zyban
13.14.2.1.2. Chantix
13.15. Rest of Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
13.15.1. Online
13.15.2. Offline
13.16. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
13.16.1. By Product Type
13.16.2. By Distribution Channel
13.17. PEST Analysis
13.18. Key Trends
13.19. Key Development

14. South America Smoking Cessation and Nicotine De-Addiction Market Analysis
14.1. Key Findings
14.2. South America Smoking Cessation and Nicotine De-Addiction Market Overview
14.3. South America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Product Type
14.4. South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.4.1. Products (with Nicotine)
14.4.1.1. OTC Products
14.4.1.1.1. E-cigarettes
14.4.1.1.2. Nicotine Gums (NRT)
14.4.1.1.3. Nicotine Patches (NRT)
14.4.1.1.4. Nicotine Lozenges (NRT)
14.4.1.1.5. Nicotine Tablets (NRT)
14.4.1.2. Prescription Products
14.4.1.2.1. Nicotine Sprays (NRT)
14.4.1.2.2. Nicotine Inhalers (NRT)
14.4.2. Products (without Nicotine)
14.4.2.1. Prescription Products
14.4.2.1.1. Zyban
14.4.2.1.2. Chantix
14.5. South America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Distribution Channel
14.6. South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.6.1. Online
14.6.2. Offline
14.7. South America Smoking Cessation and Nicotine De-Addiction Market Value Share Analysis, by Country
14.8. South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. South America Smoking Cessation and Nicotine De-Addiction Market Analysis, by Country
14.10. Brazil Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.10.1. Products (with Nicotine)
14.10.1.1. OTC Products
14.10.1.1.1. E-cigarettes
14.10.1.1.2. Nicotine Gums (NRT)
14.10.1.1.3. Nicotine Patches (NRT)
14.10.1.1.4. Nicotine Lozenges (NRT)
14.10.1.1.5. Nicotine Tablets (NRT)
14.10.1.2. Prescription Products
14.10.1.2.1. Nicotine Sprays (NRT)
14.10.1.2.2. Nicotine Inhalers (NRT)
14.10.2. Products (without Nicotine)
14.10.2.1. Prescription Products
14.10.2.1.1. Zyban
14.10.2.1.2. Chantix
14.11. Brazil Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.11.1. Online
14.11.2. Offline
14.12. Mexico Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.12.1. Products (with Nicotine)
14.12.1.1. OTC Products
14.12.1.1.1. E-cigarettes
14.12.1.1.2. Nicotine Gums (NRT)
14.12.1.1.3. Nicotine Patches (NRT)
14.12.1.1.4. Nicotine Lozenges (NRT)
14.12.1.1.5. Nicotine Tablets (NRT)
14.12.1.2. Prescription Products
14.12.1.2.1. Nicotine Sprays (NRT)
14.12.1.2.2. Nicotine Inhalers (NRT)
14.12.2. Products (without Nicotine)
14.12.2.1. Prescription Products
14.12.2.1.1. Zyban
14.12.2.1.2. Chantix
14.13. Mexico Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.13.1. Online
14.13.2. Offline
14.14. Rest of South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Product Type
14.14.1. Products (with Nicotine)
14.14.1.1. OTC Products
14.14.1.1.1. E-cigarettes
14.14.1.1.2. Nicotine Gums (NRT)
14.14.1.1.3. Nicotine Patches (NRT)
14.14.1.1.4. Nicotine Lozenges (NRT)
14.14.1.1.5. Nicotine Tablets (NRT)
14.14.1.2. Prescription Products
14.14.1.2.1. Nicotine Sprays (NRT)
14.14.1.2.2. Nicotine Inhalers (NRT)
14.14.2. Products (without Nicotine)
14.14.2.1. Prescription Products
14.14.2.1.1. Zyban
14.14.2.1.2. Chantix
14.15. Rest of South America Smoking Cessation and Nicotine De-Addiction Market Forecast, by Distribution Channel
14.15.1. Online
14.15.2. Offline
14.16. South America Smoking Cessation and Nicotine De-Addiction Market Attractiveness Analysis
14.16.1. By Product Type
14.16.2. By Distribution Channel
14.17. PEST Analysis
14.18. Key Trends
14.19. Key Development

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Applications
15.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
15.3. Company Profiles: Key Players
15.3.1. Pfizer Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Company Footprint
15.3.2. GlaxoSmithKline plc (GSK)
15.3.3. Cipla Ltd.
15.3.4. Johnson & Johnson (J&J)
15.3.5. ITC Ltd.
15.3.6. Takeda Pharmaceutical Company Ltd.
15.3.7. Alkalon A/S
15.3.8. 22nd Century Group, Inc.
15.3.9. Strides Pharma Science Ltd.
15.3.10. JUUL Labs, Inc.
15.3.11. Imperial Brands
15.3.12. Japan Tobacco Inc.
15.3.13. British American Tobacco
15.3.14. Perrigo Company plc
15.3.15. Fertin Pharma

16. Primary Key Insights
  • INQUIRE BEFORE BUYING